No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Benzimidazoles / administration & dosage
-
Carcinoma, Renal Cell* / drug therapy
-
Carcinoma, Renal Cell* / secondary
-
Everolimus
-
Humans
-
Indoles / administration & dosage
-
Kidney Neoplasms* / drug therapy
-
Kidney Neoplasms* / pathology
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / secondary
-
Male
-
Middle Aged
-
Neoplasm Metastasis
-
Pyrroles / administration & dosage
-
Quinolones / administration & dosage
-
Sirolimus / administration & dosage
-
Sirolimus / analogs & derivatives
-
Sunitinib
-
TOR Serine-Threonine Kinases / antagonists & inhibitors*
Substances
-
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
-
Antineoplastic Agents
-
Benzimidazoles
-
Indoles
-
Pyrroles
-
Quinolones
-
Everolimus
-
TOR Serine-Threonine Kinases
-
Sunitinib
-
Sirolimus